 Cell Transformation, Neoplastic
"Cell Transformation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Descriptor ID |
D002471
|
| MeSH Number(s) |
C04.697.152 C23.550.727.152
|
| Concept/Terms |
Cell Transformation, Neoplastic- Cell Transformation, Neoplastic
- Cell Transformations, Neoplastic
- Neoplastic Cell Transformations
- Transformations, Neoplastic Cell
- Neoplastic Transformation, Cell
- Cell Neoplastic Transformation
- Cell Neoplastic Transformations
- Neoplastic Transformations, Cell
- Transformation, Cell Neoplastic
- Transformations, Cell Neoplastic
- Transformation, Neoplastic Cell
- Tumorigenic Transformation
- Transformation, Tumorigenic
- Transformations, Tumorigenic
- Tumorigenic Transformations
- Oncogenesis
- Oncogeneses
- Neoplastic Cell Transformation
- Tumorigenesis
- Tumorigeneses
|
Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Neoplastic".
This graph shows the total number of publications written about "Cell Transformation, Neoplastic" by people in this website by year, and whether "Cell Transformation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 1 | 0 | 1 | | 1982 | 0 | 1 | 1 | | 1983 | 2 | 0 | 2 | | 1984 | 0 | 1 | 1 | | 1986 | 1 | 0 | 1 | | 1987 | 0 | 1 | 1 | | 1988 | 1 | 1 | 2 | | 1989 | 1 | 3 | 4 | | 1990 | 1 | 0 | 1 | | 1991 | 3 | 0 | 3 | | 1993 | 2 | 0 | 2 | | 1994 | 3 | 0 | 3 | | 1995 | 3 | 1 | 4 | | 1996 | 2 | 0 | 2 | | 1997 | 2 | 2 | 4 | | 1998 | 2 | 2 | 4 | | 1999 | 1 | 4 | 5 | | 2000 | 4 | 4 | 8 | | 2001 | 3 | 1 | 4 | | 2002 | 5 | 3 | 8 | | 2003 | 2 | 4 | 6 | | 2004 | 9 | 5 | 14 | | 2005 | 3 | 4 | 7 | | 2006 | 5 | 6 | 11 | | 2007 | 6 | 5 | 11 | | 2008 | 8 | 3 | 11 | | 2009 | 7 | 2 | 9 | | 2010 | 4 | 3 | 7 | | 2011 | 2 | 9 | 11 | | 2012 | 6 | 5 | 11 | | 2013 | 7 | 4 | 11 | | 2014 | 3 | 6 | 9 | | 2015 | 8 | 4 | 12 | | 2016 | 4 | 6 | 10 | | 2017 | 3 | 3 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Transformation, Neoplastic" by people in Profiles.
-
Corrias G, Escalon JG, Tang L, Monti S, Saba L, Mannelli L. Hepatic angiosarcomatous transformation of a mediastinal germinal cell tumor: A care case report. Medicine (Baltimore). 2017 Dec; 96(51):e9152.
-
DeGregori J. Connecting Cancer to Its Causes Requires Incorporation of Effects on Tissue Microenvironments. Cancer Res. 2017 Nov 15; 77(22):6065-6068.
-
Gasparetto M, Smith CA. ALDHs in normal and malignant hematopoietic cells: Potential new avenues for treatment of AML and other blood cancers. Chem Biol Interact. 2017 Oct 01; 276:46-51.
-
Mello SS, Sinow C, Raj N, Mazur PK, Bieging-Rolett K, Broz DK, Imam JFC, Vogel H, Wood LD, Sage J, Hirose T, Nakagawa S, Rinn J, Attardi LD. Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes Dev. 2017 06 01; 31(11):1095-1108.
-
Suda K, Murakami I, Yu H, Kim J, Ellison K, Rivard CJ, Mitsudomi T, Hirsch FR. Heterogeneity in Immune Marker Expression after Acquisition of Resistance to EGFR Kinase Inhibitors: Analysis of a Case with Small Cell Lung Cancer Transformation. J Thorac Oncol. 2017 Jun; 12(6):1015-1020.
-
Liggett LA, DeGregori J. Changing mutational and adaptive landscapes and the genesis of cancer. Biochim Biophys Acta. 2017 04; 1867(2):84-94.
-
Henry WS, Hendrickson DG, Beca F, Glass B, Lindahl-Allen M, He L, Ji Z, Struhl K, Beck AH, Rinn JL, Toker A. LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. Oncotarget. 2016 Dec 13; 7(50):81981-81994.
-
Jian Z, Strait A, Jimeno A, Wang XJ. Cancer Stem Cells in Squamous Cell Carcinoma. J Invest Dermatol. 2017 Jan; 137(1):31-37.
-
Rigby CM, Roy S, Deep G, Guillermo-Lagae R, Jain AK, Dhar D, Orlicky DJ, Agarwal C, Agarwal R. Role of p53 in silibinin-mediated inhibition of ultraviolet B radiation-induced DNA damage, inflammation and skin carcinogenesis. Carcinogenesis. 2017 Jan; 38(1):40-50.
-
Keysar SB, Le PN, Miller B, Jackson BC, Eagles JR, Nieto C, Kim J, Tang B, Glogowska MJ, Morton JJ, Padilla-Just N, Gomez K, Warnock E, Reisinger J, Arcaroli JJ, Messersmith WA, Wakefield LM, Gao D, Tan AC, Serracino H, Vasiliou V, Roop DR, Wang XJ, Jimeno A. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. J Natl Cancer Inst. 2017 01; 109(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|